Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases PharmacistsEric Wenzler, Elizabeth B. Hirsch, Mira Maximos et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2023Cited by 61
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and MethodsBarbara W. Trautner, Valéry Lavergne, Nicolás Cortés-Penfield et al.|Clinical Infectious Diseases|2025Cited by 11
Clinical Practice Guidelines by Infectious Diseases Society of America (IDSA): 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections—Duration of Antibiotics for Complicated UTIBarbara W. Trautner, Valéry Lavergne, Nicolás Cortés-Penfield et al.|Clinical Infectious Diseases|2025Cited by 9
Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections – Timing of Intravenous to Oral Antibiotics Transition for Complicated Urinary Tract InfectionsBarbara W. Trautner, Valéry Lavergne, Nicolás Cortés-Penfield et al.|Clinical Infectious Diseases|2025Cited by 8
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 SeropositivityAlyssa Christensen, Sarah Rebecca Peglow, Ethan Ryberg et al.|Clinical Infectious Diseases|2025Cited by 0